The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen

International Journal of Oncology

Volumn 28, Issue 4, 2006, Pages 947-953

  Ojima, Toshiyasu ^a   Iwahashi, Makoto ^a   Nakamura, Masaki ^a   Matsuda, Kenji ^a   Naka, Teiji ^a   Nakamori, Mikihito ^a   Ueda, Kentaro ^a   Ishida, Koichiro ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Dendritic cells; gp70; Granulocyte macrophage colony stimulating factor; Interleukin 12

Indexed keywords

CANCER VACCINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; TUMOR ANTIGEN;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; NATURAL KILLER CELL; PATHOLOGY; SECRETION; SPLEEN; TRANSPLANTATION; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-12; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 33744775341     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.4.947     Document Type: Article

References (36)

1. Austyn JM: New insights into the mobilization and phagocytic activity of dendritic cells. J Exp Med 183: 1287-1292, 1996.
2. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
3. Gately MK, Wolitzky AG, Quinn PM and Chizzonite R: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143: 127-142, 1992.
4. Nakamura M, Iwahashi M, Nakamori M, Ueda K, Ojima T, Naka T, Ishida K and Yamaue H: Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. Oncology 68: 163-170, 2005.
5. Jonuleit H, Knop J and Enk AH: Cytokines and their effects on maturation, differentiation and migration of dendritic cells. Arch Dermatol Res 289: 1-8, 1996.
6. Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179: 1109-1118, 1994.
7. Nakamura M, Iwahashi M, Nakamori M, Ueda K, Matsuura I, Noguchi K and Yamaue H: Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Clin Cancer Res 8: 2742-2749, 2002.
8. Braun SE, Chen K, Foster RG, Kim CH, Hromas R, Kaplan MH, Broxmeyer HE and Cornetta K: The CC Chemokine CK β-11/MIP-3 β/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. J Immunol 164: 4025-4031, 2000.
9. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B and Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF); a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845, 1989.
10. Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R and Gately MK: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87: 6808-6812, 1990.
11. Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P and O'Keeffe M: Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 166: 5448-5455, 2001.
12. Stober D, Schirmbeck R and Reimann J: IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J Immunol 167: 957-965, 2001.
13. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A and Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184: 747-752, 1996.
14. Pan PY, Gu P, Li Q, Xu D, Weber K and Chen SH: Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation. J Immunol 172: 4779-4789, 2004.
15. Fukao T, Matsuda S and Koyasu S: Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-γ production by dendritic cells. J Immunol 164: 64-71, 2000.
16. Huang AY, Gulden PH, Woods AS, Thomas MC, Tong CD, Wang W, Engelhard VH, Pasternack G, Cotter R, Hunt D, Pardoll DM and Jaffee EM: The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci USA 93: 9730-9735, 1996.
17. Ueda K, Iwahashi M, Nakamori M, Nakamura M, Matsuura I, Yamaue H and Tanimura H: Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the Cre/loxP system in the orthotopic gastric carcinoma model. Cancer Res 61: 6158-6162, 2001.
18. Ueda K, Iwahashi M, Matsuura I, Nakamori M, Nakamura M, Ojima T, Naka T, Ishida K, Matsumoto K, Nakamura T and Yamaue H: Adenoviral-mediated gene transduction of the hepatocyte growth factor antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice. Eur J Cancer 40: 2135-2142, 2004.
19. Kay MA, Graham F, Leland F and Woo SL: Therapeutic serum concentrations of human alpha 1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21: 815-819, 1995.
20. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N and Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92, 1999.
21. Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Tamai M, Noguchi K and Hotta T: Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients. Int J Cancer 51: 67-71, 1992.
22. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R and Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-1186, 1999.
23. + T cells. Nat Immunol 2: 1010-1017, 2001.
24. Reis e Sousa C, Hieny S, Scharton-Kersten T, Jankovic D, Charest H, Germain RN and Sher A: In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their redistribution to T cell areas. J Exp Med 186: 1819-1829, 1997.
25. Hill HC, Conway TF Jr, Sabel MS, Jong YS, Mathiowitz E, Bankert RB and Egilmez NK: Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res 62: 7254-7263, 2002.
26. Wang J, Snider DP, Hewlett BR, Lukacs NW, Gauldie J, Liang H and Xing Z: Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung. Blood 95: 2337-2345, 2000.
27. Nishimura N, Nishioka Y, Shinohara T and Sone S: Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells. Hum Gene Ther 12: 333-346, 2001. (Pubitemid 32186646)
28. Raulet DH: Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5: 996-1002, 2004.
29. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G and Trinchieri G: Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195: 327-333, 2002.
30. Fernandez NC, Lozier A, Flament C, Ricciardi-Castahndi P, Bellet D, Suter M, Perricaudet M, Tursz T and Maraskovsky E: Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5: 405-411, 1999.
31. Zatloukal K, Schneeberger A, Berger M, Schmidt W, Koszik F, Kutil R, Cotton M, Wagner E, Buschle M and Maass G: Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters. J Immunol 154: 3406-3419, 1995.
32. + T helper cell responses in tumor immunity. Immunol Lett 74: 75-79, 2000.
33. Heike M, Schlaak J, Schulze-Bergkamen H, Heyl S, Herr W, Schmitt U, Schneider PM and Meyer zum Buschenfelde KH: Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens. J Immunol 156: 2205-2213, 1996.
34. Tatsumi T, Huang J, Gooding WE, Gambotto A, Robbins PD, Vujanovic NL, Alber SM, Watkins SC, Okada H and Storkus WJ: Intratumoral delivery of dendritic cells engineered to secrete both Interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc 1-type immunity. Cancer Res 63: 6378-6386, 2003.
35. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G and Romagnani S: Natural killer cell stimulatory factor [interleukin 12 (IL-12)] induces T helper type 1 (Th 1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199-1204, 1993.
36. Van den Broeke LT, Daschbach E, Thomas EK, Andringa G and Berzofsky JA: Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol 171: 5842-5452, 2003.